Skip Navigation


BJA Advance Access originally published online on March 5, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/5/712    most recent
aeh126v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Liu, K. S.
Right arrow Articles by Wang, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, K. S.
Right arrow Articles by Wang, J. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2004, Vol. 92, No. 5 712-715
© 2004 The Board of Management and Trustees of the British Journal of Anaesthesia

Laboratory Investigations

Antinociceptive effect of a novel long-acting nalbuphine preparation{dagger}

K. S. Liu1,2, O. Y. P. Hu3, S. T. Ho4, J. I. Tzeng1, Y. W. Chen1 and J. J. Wang*,1

1 Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan. 2 Department of Chemistry, National Cheng Kung University, Tainan, Taiwan. 3 Department of Research and Education, National Defense Medical Center, Taipei, Taiwan. 4 Department of Anesthesiology, Tri-Service General Hospital, Taipei, Taiwan

*Corresponding author. E-mail: 400002{at}mail.chimei.org.tw
{dagger}This work was done in the Chi-Mei Medical Center, Tainan, Taiwan.

Background. A long-acting analgesic may be particularly desirable in patients suffering from long-lasting pain. The aim of the study was to evaluate the antinociceptive effect of a novel nalbuphine preparation and to determine its duration of action.

Methods. The antinociceptive effects of i.m. nalbuphine HCl in saline and nalbuphine base in sesame oil were evaluated in rats. The in vitro drug-releasing profiles of nalbuphine HCl and base in different preparations were also evaluated.

Results. We found that i.m. nalbuphine HCl 25, 50 and 100 µmol kg–1 produced dose-related antinociceptive effects with a duration of action of 1.5, 2 and 3 h, respectively. I.M. nalbuphine base 100, 200 and 400 µmol kg–1 also produced dose-related antinociceptive effects but with longer durations of action: 27, 49 and 55 h, respectively. In vitro studies demonstrated that nalbuphine base in sesame oil had the slowest drug-releasing profile of the different preparations.

Conclusions. I.M. injection of an oil formulation of nalbuphine base produced a long-lasting antinociceptive effect.

Br J Anaesth 2004; 92: 712–15


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
N. Dietis, R. Guerrini, G. Calo, S. Salvadori, D. J. Rowbotham, and D. G. Lambert
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile
Br. J. Anaesth., July 1, 2009; 103(1): 38 - 49.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.